NCT07125352 Neutrophil to Lymphocyte Ratio in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
| NCT ID | NCT07125352 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Chronic Obstructive Pulmonary Disease Exacerbation |
| Study Type | OBSERVATIONAL |
| Enrollment | 190 participants |
| Start Date | 2025-05-20 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 190 participants in total. It began in 2025-05-20 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chronic obstructive pulmonary disease (COPD) stands as one of the leading causes of mortality worldwide. Acute exacerbations of COPD (AECOPD) lead to rapid respiratory function decline and worsened disease status. Despite recent studies, the ability of the neutrophil-to-lymphocyte ratio (NLR) to predict outcomes in patients with COPD remains controversial. It remains controversial whether NLR can predict clinical outcomes in hospitalized patients with AECOPD. Therefore, this study was conducted to investigate the predictive value of NLR for severity, adverse outcomes in hospitalized patients with AECOPD, and predicting treatment response in patients with AECOPD
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 and above, Patients who will be admitted at the Chest department, Ain-Shams University Hospitals, diagnosed with AECOPD based on the Global Initiative for Chronic Obstructive Lung Disease 2024 criteria Exclusion Criteria: * Patients who refused treatment. * COPD patients with Malignancy, hematological disorders
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07125352 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Obstructive Pulmonary Disease Exacerbation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07125352 currently recruiting?
Yes, NCT07125352 is actively recruiting participants. Contact the research team at hiebagamal24@med.asu.edu.eg for enrollment information.
Where is the NCT07125352 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07125352 clinical trial?
NCT07125352 is sponsored by Ain Shams University. The trial plans to enroll 190 participants.